{"cdcTestId":"2013-0427","testcaseName":"#2 @ 9 yrs, 4 wks - 4 days, female, Cervarix ","vaccineGroup":"HPV","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2011-05-25T00:00:00","patient":{"dob":"2002-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2011-04-28T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-25T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2011-09-28T00:00:00","recommendedDate":"2011-10-28T00:00:00","pastDueDate":"2012-06-24T00:00:00"},"doses":[{"dateAdministered":"2011-04-28T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-25T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-08T15:35:17.782","generalDescription":"This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.","changedInVersion":"3.2","reasonForChange":"Updated to reflect ACIP recommendations for the HPV 2 dose series."}